Product Information
FESOTERODINE ER 8 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.8393 per EA under NDC 68382048006. Its NADAC has been published 207 times since Oct 19, 2022.
FDA first approved this application on Oct 3, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382048006
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FESOTERODINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA204946FDA Approved
10/3/2017
TE Code
AB
On Market Since
12/7/2017
Price Statistics
The NADAC for FESOTERODINE ER 8 MG TABLET has been published 207 times since Oct 19, 2022, and over the history we have for it it has declined 21.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8393 per EA |
|---|---|
| All-time high | $1.1822 (Apr 12, 2023) |
| All-time low | $0.7258 (Nov 20, 2024) |
| 52-week high | $0.9311 |
| 52-week low | $0.8127 |
| Median price | $0.9219 |
| Average price | $0.9366 |
| Largest weekly change | -25.2% (Apr 17, 2024) |
| Weeks tracked | 207 |
| Tracking since | Oct 19, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fesoterodine fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FESOTERODINE ER 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FESOTERODINE ER 8 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.8393 per EA (NDC 68382048006), effective Sep 30, 2026.
How has the price of FESOTERODINE ER 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for FESOTERODINE ER 8 MG TABLET has declined 21.0%. It has been tracked across 207 weekly CMS publications since Oct 19, 2022.
What are the highest and lowest recorded NADAC prices for FESOTERODINE ER 8 MG TABLET?
Since Oct 19, 2022, the NADAC for FESOTERODINE ER 8 MG TABLET has ranged from a low of $0.7258 (Nov 20, 2024) to a high of $1.1822 (Apr 12, 2023), with a median of $0.9219 per EA.
Are there cheaper alternatives to FESOTERODINE ER 8 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as FESOTERODINE ER 8 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FESOTERODINE ER 8 MG TABLET?
FESOTERODINE ER 8 MG TABLET (NDC 68382048006) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.